The investment, completed last month, reflects Prelude Growth's strong conviction in OneSkin's mission and potential, and marks a significant milestone in the brand's next chapter of growth.

Founded by four female PhD scientists with deep expertise in stem cell biology, bioinformatics, and tissue engineering, OneSkin is a skin longevity company committed to transform skincare into skin longevity-developing scientifically proven products that optimize skin's biology at the cellular level, reversing signs of aging while supporting overall healthspan.